The Business Research Company’s Gene Therapy Global Market Report 2021 – COVID 19 Growth And Change
LONDON, GREATER LONDON, UK, November 1, 2021 /EINPresswire.com/ — According to the new market research report ‘Gene Therapy Global Market Report 2021: COVID-19 Growth And Change’ published by The Business Research Company, the gene therapy market is expected to grow from $3.18 billion in 2020 to $3.97 billion in 2021 at a compound annual growth rate (CAGR) of 24.8%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $12.16 billion in 2025 at a CAGR of 32%. Incidences of cancer and other target diseases have been increasing significantly, which is calling for effective treatments, driving the growth of the gene therapy market.
Request For A Sample For The Global Gene Therapy Market Report:
The gene therapy market consists of sales of gene therapy related services by entities (organizations, sole traders and partnerships) that manufacture gene therapy drugs. Gene therapy is used to replace faulty genes or add new genes to cure disease or improve the body's ability to fight disease. Only goods and services traded between entities or sold to end consumers are included.
Trends In The Global Gene Therapy Market
The use of machine learning and artificial intelligence is gradually gaining popularity in the gene therapy market. Artificial intelligence (AI) is the simulation of human intelligence in machines, which are programmed to display their natural intelligence. Machine learning is a part of AI. Machine learning and AI help companies in the gene therapy market to conduct a detailed analysis of all relevant data, provide insights between tumor and immune cell interactions, and offer a more accurate evaluation of tissue samples often conflicted between different evaluators. For instance, since January 2020, GlaxoSmithKline, a pharmaceutical company, has been investing in AI to optimize gene therapy and develop off-the-shelf solutions for patients. It is also expected to reduce turnaround time and also the cost of gene therapies.
Global Gene Therapy Market Segments:
The global gene therapy market is further segmented:
By Gene Type: Antigen, Cytokine, Suicide Gene, Others
By Vector: Viral Vector, Non-Viral Vector, Others
By Application: Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Others
By End Users: Hospitals, Homecare, Specialty Clinics, Others
By Geography: The global gene therapy market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Report For The Global Gene Therapy Market At:
Gene Therapy Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides gene therapy global market overviews, analyzes and forecasts market size and growth for the global gene therapy market, gene therapy global market share, gene therapy global market players, gene therapy global market segments and geographies, gene therapy global market’s leading competitors’ revenues, profiles and market shares. The gene therapy market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Read Gene Therapy Global Market Report 2021 from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries
Gene Therapy Market Organizations Covered: Novartis AG, Bluebird Bio, Inc., Spark Therapeutics, Inc., Audentes Therapeutics, Voyager Therapeutics, Applied Genetic Technologies Corporation, UniQure N.V., Celgene Corporation, Cellectis S.A., Sangamo Therapeutics, Gilead Lifesciences, Inc., Orchard Therapeutics, Sibiono GeneTech Co., Ltd., Gensight Biologics S.A., Shanghai Sunway Biotech Co., Ltd., Biogen, Sarepta Therapeutics, Inc., Sangamo Therapeutics, Audentes Therapeutics, Regenxbio, Inc., Gegenxbio, Inc, Oxford BioMedica plc., Dimension Therapeutics, Inc., Bristol-Myers Suibb Company, Sanofi, Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics), Shrine Plc, Benitech Biopharma, Transgene, Epeius Biotechnologies Corp., Calimmune, Inc.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Here is a list of reports from The Business Research Company similar to the Gene Therapy Global Market Report 2021:
Cell Therapy Global Market Report 2021: COVID-19 Growth And Change
Gene Editing Global Market Report 2021: COVID-19 Growth And Change
Cell Therapy Technologies Global Market Report 2021: COVID-19 Growth And Change
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Source: EIN Presswire